Search Results

You searched for : Incyte

	Incyte announces results of phase 3 RUXCOVID study of Ruxolitinib as a treatment for patients with COVID-19 associated cytokine storm The data will be further analyzed to determine any potential impact on other studies of ruxolitinib in patients with COVID-19, and will be submitted ... Dec 15
	Xencor, MorphoSys and Incyte enter into global development collaboration for Tafasitamab in combination with Plamotamab Under the terms of the agreement, the companies plan to initiate a Phase 1/2 study evaluating the combination of tafasitamab, plamotamab and lenalidomide ... Nov 13
	BriaCell announces the overall breast cancer survival (OS) data of its lead product candidate, Bria-IMTâ„¢ Median OS of 13.3 months has been observed in the Phase I/IIa study for patients treated with Bria-IMTâ„¢ in combination with immune ... Oct 21
	ELI LILLY begins 3rd phase clinical trial with Baricitinib for COVID patients ELI Lilly close to coronavirus antiviral as 3rd phase trial begins... Jun 17
	Clinical testing of remdesivir with baricitinib for COVID-19 begins Investigators currently anticipate enrolling more than 1,000 participants... May 14
5 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

Incyte announces results of phase 3 RUXCOVID study of Ruxolitinib as a treatment for patients with COVID-19 associated cytokine storm

Xencor, MorphoSys and Incyte enter into global development collaboration for Tafasitamab in combination with Plamotamab

BriaCell announces the overall breast cancer survival (OS) data of its lead product candidate, Bria-IMTâ„¢

ELI LILLY begins 3rd phase clinical trial with Baricitinib for COVID patients

Clinical testing of remdesivir with baricitinib for COVID-19 begins

Trending Now